• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Imprivata Acquires Apple Provisioning Services Provider Groundcontrol

Share:

February 3, 2020

Imprivata®, the provider of digital identity company for healthcare, today announced the acquisition of GroundControl Solutions, Inc., a leader in cloud-based automation software for provisioning shared mobile devices. The combination of Imprivata and GroundControl innovations will advance the proliferation of Digital Identity Authorization and Access Management solutions and services for mobile devices in healthcare. It will accelerate the development of new capabilities on fleets of enterprise mobile devices for large and small enterprises.

Apple Configurator on Steroids

Founded in 2014, GroundControl helps regulated industries enhance their current mobile device management (MDM) to maintain the highest standards for provisioning, asset management, privacy, and security. Described as “Apple Configurator on steroids, GroundControl specializes in Apple iPhone and iPad, the software helps regulated industries enhance their current MDM to maintain the highest standards for provisioning, asset management, privacy, and security. GroundControl gives IT staff remote, extended reach into every location, for device repairs, resets and updates. The company’s automation rules and workflows can be configured to trigger actions whenever devices are charging — the perfect time for an OS update or refresh.

To date, GroundControl solutions have been used to support more than 1,000,000 devices at global corporations, including hospitals, retail outlets, and airports, across 82 countries worldwide.

“We are excited about the quality of people, solutions, services, and customer base this acquisition brings to Imprivata,” said Gus Malezis, President and CEO of Imprivata. “As we continue to expand our mobile device offerings, GroundControl will be a central component of Imprivata’s go-forward mobile strategy.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Due to the positive impact on productivity, cost, and security, the use of shared mobile devices has significantly increased, especially in healthcare,” said Aaron Freimark, CEO of GroundControl. “By combining forces with Imprivata, we can tap into industry-leading capabilities and resources to provide a powerful and complete identity lifecycle solution for customers around the world.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Apple, Google Partner on COVID-19 Contact Tracing Tech: 5 Things to KnowApple, Google Partner on COVID-19 Contact Tracing Tech: 5 Things to Know
  • Christiana Care Pays $47 Million to Settle Alleged kickback Scheme.Christiana Care Pays $47 Million to Settle Alleged kickback Scheme.
  • Tech Giants, Insurers, Health Stakeholders to Test Drive New Claims Data InitiativeTech Giants, Insurers, Health Stakeholders to Test Drive New Claims Data Initiative
  • Harris Williams Advises Numotion on its Sale to AEA Investors LPHarris Williams Advises Numotion on its Sale to AEA Investors LP
  • FTC, Department of Justice Release New Draft Merger GuidelinesFTC, Department of Justice Release New Draft Merger Guidelines
  • The Journey of the Employee ExperienceThe Journey of the Employee Experience
  • Transnetyx Announces Acquisition of BrainBits®Transnetyx Announces Acquisition of BrainBits®
  • Bicycle Health, Albertsons Partner to Boost Access to Opioid use Disorder InjectionsBicycle Health, Albertsons Partner to Boost Access to Opioid use Disorder Injections

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications